Immunic Doubles Down On Lead Asset With New Data In Ulcerative Colitis

 
• By Jessica Merrill
  
two roads
Immunic is exploring several paths forward for vidofludimus calcium • Source: Shutterstock

More from Clinical Trials

More from R&D